Still Upright By Debbie Oelke Disease progression is not welcome, predicted, or encouraging. Instead, it is difficult, random, and unrelenting. It is forever on my mind. Fear of the future […]
Read News ArticleAuthor: Hoff Communications
Thoughts About Giving
Ways to Support MSAA By Susan Wells Courtney Improving Lives Through Art® For more than a decade, MSAA has recognized and cultivated the artistic talents and expressions of the MS […]
Read News ArticleResearch News
Recent News and Study Updates in MS Research By Susan Wells CourtneyReviewed by Dr. Barry A. Hendin, MSAA Chief Medical Officer FDA Approves the First Biosimilar to Treat MS On […]
Read News ArticleProgram Notes
MSAA’s Vital Programs and Services Improve Lives Today By Susan Wells Courtney MSAA’s Toll-Free Helpline Do you have questions about MS, its symptoms, or its treatments? Each year, several thousand […]
Read News ArticleAsk the Doctor
Questions from our Readers Dr. Barry A. Hendin By Dr. Barry A. Hendin MSAA’s Chief Medical Officer Q: I suffer from achalasia, similar to dysphagia. I have difficulty swallowing and […]
Read News ArticleDiet and MS: The Gut Microbiome Connection
SEE ALSO Cover Story: The Importance of Diet and Nutrition in MS We all know that the digestive system is the mediator between what we eat and how those foods […]
Read News ArticleCover Story
By Tom GarryEdited by Susan Wells CourtneyReviewed by Barry A. Hendin, MD SEE ALSO: Diet and MS: The Gut Microbiome Connection Although more research is needed, studies have shown that […]
Read News ArticleUp Front
MSAA Embarks Upon a New Strategic Plan Gina Ross Murdoch By Gina Ross MurdochMSAA President and CEO I hope that all of our readers were able to “weather” the dangerous […]
Read News ArticleThe Motivator – Summer/Fall 2023
View/Download PDF View Digital Edition Order a Copy Cover Story The Importance of Diet and Nutrition in MS By Tom Garry Medical professionals provide insights into healthy food choices for […]
Read News ArticleWhat’s New in MS Research – September 2023
This edition of “What’s New in MS Research” opens with a pair of “firsts:” the first listing of multiple sclerosis (MS) therapies on the World Health Organization’s List of Essential Medicines and the first United States Food and Drug Administration (FDA) approval of a biosimilar therapy for the long-term treatment of MS.
Read News Article